- Home
- NVS vs SPGI Comparison
NVS vs SPGI Comparison
Compare NVS & SPGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVS | SPGI |
|---|---|---|
| Founded | 1895 | 1860 |
| Country | Switzerland | United States |
| Employees | 75267 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.4B | 160.5B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | NVS | SPGI |
|---|---|---|
| Price | $162.92 | $446.16 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 15 |
| Target Price | $118.00 | ★ $566.87 |
| AVG Volume (30 Days) | 2.5M | ★ 3.3M |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | ★ 1.94% | 0.86% |
| EPS Growth | N/A | ★ 18.70 |
| EPS | N/A | ★ 14.66 |
| Revenue | N/A | ★ $6,063,000,000.00 |
| Revenue This Year | $2.56 | $9.70 |
| Revenue Next Year | $4.91 | $7.36 |
| P/E Ratio | ★ $23.13 | $30.72 |
| Revenue Growth | N/A | ★ 7.10 |
| 52 Week Low | $97.72 | $381.61 |
| 52 Week High | $170.46 | $579.05 |
Technical Indicators
Market Signals| Indicator | NVS | SPGI |
|---|---|---|
| Relative Strength Index (RSI) | 55.63 | 48.06 |
| Support Level | $113.19 | $400.52 |
| Resistance Level | $170.46 | $500.93 |
| Average True Range (ATR) | 2.50 | 10.80 |
| MACD | -1.22 | 6.92 |
| Stochastic Oscillator | 47.16 | 89.25 |
Price Performance
Historical ComparisonAbout NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
About SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.